Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Shirabe

Showing results (391-400 of 834) with videos related to

Pageof 84
Sort By:
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|April 23, 2013
CD4 T cell-mediated masking effects of the immunogenicity of tumor-associated antigens are qualitatively and quantitatively different depending on the individual antigensShinji Okano, Yoshihiro Matsumoto, Shohei Yoshiya, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 8, 2013
Hepatic interferon-gamma-induced protein-10 expression is more strongly associated with liver fibrosis than interleukin-28B single nucleotide polymorphisms in hepatocellular carcinoma resected patients with chronic hepatitis CHideyuki Konishi, Ken Shirabe, Shohei Yoshiya, et al.
Surgery|August 27, 2013
Third or more repeat hepatectomy for recurrent hepatocellular carcinomaYo-ichi Yamashita, Ken Shirabe, Eiji Tsuijita, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2013
Re-evaluation of the predictive score for 6-month graft survival in living donor liver transplantation in the modern eraTomoharu Yoshizumi, Toru Ikegami, Yuki Bekki, et al.
Anticancer Research|March 10, 2015
Surgical loupes at 5.0× magnification and the VIO soft-coagulation system can prevent postoperative pancreatic fistula in duct-to-mucosa pancreaticojejunostomyYo-Ichi Yamashita, Yoshihiro Yoshida, Takeshi Kurihara, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 17, 2015
Risk factors for hepatitis B virus recurrence after living donor liver transplantation: A 17-year experience at a single centerSung Kwan Bae, Shinji Shimoda, Toru Ikegami, et al.
JTCVS Open|August 25, 2022
Inflammatory and immune checkpoint markers are associated with the severity of aortic stenosisBilguun Erkhem-Ochir, Wataru Tatsuishi, Takehiko Yokobori, et al.
Clinical Journal of Gastroenterology|July 18, 2015
Thrombotic microangiopathy caused by severe graft dysfunction after living donor liver transplantation: report of a caseDaisuke Matsuda, Takeo Toshima, Toru Ikegami, et al.
Annals of Surgical Oncology|July 11, 2015
Clinicopathologic Features and Outcomes of Non-B, Non-C Hepatocellular Carcinoma After HepatectomyKazuki Takeishi, Takashi Maeda, Ken Shirabe, et al.
Anticancer Research|July 29, 2016
Validity of Hepatic or Pancreatic Resection for Elderly Patients Aged 85 Years or Older at a Single Community Hospital in JapanShinji Itoh, Shunji Kohnoe, Ken Shirabe, et al.
Pageof 84

Showing results (391-400 of 834) with videos related to

Sort By:
Pageof 84
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|April 23, 2013
CD4 T cell-mediated masking effects of the immunogenicity of tumor-associated antigens are qualitatively and quantitatively different depending on the individual antigensShinji Okano, Yoshihiro Matsumoto, Shohei Yoshiya, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 8, 2013
Hepatic interferon-gamma-induced protein-10 expression is more strongly associated with liver fibrosis than interleukin-28B single nucleotide polymorphisms in hepatocellular carcinoma resected patients with chronic hepatitis CHideyuki Konishi, Ken Shirabe, Shohei Yoshiya, et al.
Surgery|August 27, 2013
Third or more repeat hepatectomy for recurrent hepatocellular carcinomaYo-ichi Yamashita, Ken Shirabe, Eiji Tsuijita, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2013
Re-evaluation of the predictive score for 6-month graft survival in living donor liver transplantation in the modern eraTomoharu Yoshizumi, Toru Ikegami, Yuki Bekki, et al.
Anticancer Research|March 10, 2015
Surgical loupes at 5.0× magnification and the VIO soft-coagulation system can prevent postoperative pancreatic fistula in duct-to-mucosa pancreaticojejunostomyYo-Ichi Yamashita, Yoshihiro Yoshida, Takeshi Kurihara, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 17, 2015
Risk factors for hepatitis B virus recurrence after living donor liver transplantation: A 17-year experience at a single centerSung Kwan Bae, Shinji Shimoda, Toru Ikegami, et al.
JTCVS Open|August 25, 2022
Inflammatory and immune checkpoint markers are associated with the severity of aortic stenosisBilguun Erkhem-Ochir, Wataru Tatsuishi, Takehiko Yokobori, et al.
Clinical Journal of Gastroenterology|July 18, 2015
Thrombotic microangiopathy caused by severe graft dysfunction after living donor liver transplantation: report of a caseDaisuke Matsuda, Takeo Toshima, Toru Ikegami, et al.
Annals of Surgical Oncology|July 11, 2015
Clinicopathologic Features and Outcomes of Non-B, Non-C Hepatocellular Carcinoma After HepatectomyKazuki Takeishi, Takashi Maeda, Ken Shirabe, et al.
Anticancer Research|July 29, 2016
Validity of Hepatic or Pancreatic Resection for Elderly Patients Aged 85 Years or Older at a Single Community Hospital in JapanShinji Itoh, Shunji Kohnoe, Ken Shirabe, et al.
Pageof 84